The device and generic drug industries are asking the Trump administration to back off proposed tariffs on Chinese imports they said will drive up costs and lead to drug and device shortages.
The proposal for an additional 25 percent in duties will affect at least $3 billion of medical devices and diagnostics, and related components, from China annually, the trade group for the medical device industry said. The Advanced Medical Technology Association provided the group’s prepared statement to Bloomberg Law ahead of May 17 testimony before the U.S. Trade Representative on the proposal, which would affect about 1,300 Chinese goods ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.